Bausch Health Companies Inc. (BHC)
NYSE: BHC · IEX Real-Time Price · USD
7.13
+0.08 (1.13%)
Nov 30, 2023, 12:36 PM EST - Market open
Bausch Health Companies Stock Forecast
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for BHC stock stock is $12, which predicts an increase of 68.30%. The lowest target is $8.00 and the highest is $16. On average, analysts rate BHC stock stock as a buy.
Analyst Consensus: Buy
* Price targets were last updated on Sep 20, 2023.
Analyst Ratings
The average analyst rating for BHC stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $9 → $16 | Hold → Strong Buy | Upgrades | $9 → $16 | +124.40% | Sep 20, 2023 |
| TD Cowen | TD Cowen | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 16, 2023 |
| Jefferies | Jefferies | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +33.24% | May 22, 2023 |
| RBC Capital | RBC Capital | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +12.20% | May 5, 2023 |
| Piper Sandler | Piper Sandler | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | -15.85% | Sep 9, 2022 |
Financial Forecast
Revenue This Year
8.58B
from 8.12B
Increased by 5.60%
Revenue Next Year
9.00B
from 8.58B
Increased by 4.86%
EPS This Year
3.28
from -0.62
EPS Next Year
3.78
from 3.28
Increased by 15.06%
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 9.0B | 9.9B | 9.5B | 9.7B | 9.7B |
| Avg | 8.6B | 9.0B | 9.1B | 9.3B | 9.4B |
| Low | 8.2B | 8.5B | 8.6B | 9.0B | 9.1B |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 10.8% | 15.3% | 5.6% | 7.4% | 4.5% |
| Avg | 5.6% | 4.9% | 0.8% | 2.8% | 0.5% |
| Low | 1.4% | -1.1% | -4.2% | -0.8% | -2.5% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 3.59 | 4.52 | 4.67 | 4.94 | 5.15 |
| Avg | 3.28 | 3.78 | 4.26 | 4.72 | 4.95 |
| Low | 3.08 | 3.19 | 3.82 | 4.56 | 4.80 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | 37.5% | 23.7% | 15.9% | 9.0% |
| Avg | - | 15.1% | 12.7% | 10.9% | 4.8% |
| Low | - | -3.0% | 1.2% | 7.0% | 1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.